Tenelo M Extended-Release Tablet 10/500 mg

Adult dose

This medication is typically administered once daily with the evening meal. The 20/1000 mg extended-release tablet is taken once daily, with one tablet per dose. The 10/750 mg or 10/500 mg extended-release tablets are taken once daily, with two tablets taken simultaneously. The initial dose should provide 20 mg of Teneligliptin once daily along with the existing dose of Metformin. To maintain the extended-release characteristics, do not split, crush, grind, or chew the tablets.

This medication is helpful in controlling blood sugar levels. However, it should not be used in patients with impaired renal function or heart problems. Additionally, it should be discontinued 48 hours prior to tests involving iodine contrast agents and can be resumed only after normal renal function is confirmed post-exam. It is advisable for women who are pregnant or may become pregnant to refrain from using this medication. Regular monitoring of liver and kidney function is necessary during treatment, especially in the elderly, as they may have diminished kidney function. Furthermore, this medication can rarely cause a serious condition called lactic acidosis, so if sudden illness occurs, or if there is difficulty breathing, muscle pain, abdominal pain, or weakness, consult a physician immediately. When using this medication with other diabetes drugs, hypoglycemia may occur, so it's important to be aware of the symptoms of hypoglycemia and how to respond. Excessive alcohol consumption may increase the risk of side effects associated with this medication, hence avoiding alcohol is recommended. In situations such as surgery, severe infections, or serious trauma, the medication should be temporarily discontinued and can be resumed upon recovery. This medication may cause side effects such as liver dysfunction, pancreatitis, skin rash, and joint pain in some patients, so report any abnormal symptoms to healthcare providers. Lastly, it is recommended not to use this medication in children and adolescents due to established safety and efficacy concerns.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, difficulty breathing or shortness of breath, asthma attacks, respiratory abnormalities accompanied by coughing and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary issues.

Mild side effects

• Hypoglycemia
• constipation
• dizziness
• headache
• tremor
• weakness
• hunger
• fatigue
• facial swelling
• diarrhea

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature to preserve the medication's effectiveness for a longer period.

Appearance

Orange oval extended-release film-coated tablet

Package unit

30 tablets/bottle